ClinicalTrials.Veeva

Menu

Microbial Colonization of Dairy Free Oral Probiotics

J

John Hale

Status

Unknown

Conditions

Microbial Colonization

Treatments

Dietary Supplement: Streptococcus salivarius M18 dairy free lozenges
Dietary Supplement: Streptococcus salivarius M18 lozenges

Study type

Interventional

Funder types

Industry

Identifiers

NCT05375396
BLTCT2022/4

Details and patient eligibility

About

The aim of this study is to evaluate the colonization efficacy of probiotic lozenges containing dairy and dairy free probiotic Streptococcus salivarius M18, in healthy adults

Full description

This is a double-blind, randomized controlled colonization pilot study with no cross over to evaluate the colonization efficacy of two different lozenges containing either dairy or dairy free probiotic bacteria Streptococcus salivarius M18.

Participants will be randomly assigned to one of the 2 groups consuming probiotic lozenge containing dairy free Streptococcus salivarius M18 or dairy based Streptococcus salivarius M18 over a seven day period. Saliva samples will be collected at predetermined time points pre and post intervention. Colonization efficacy will be determined by enumerating the probiotic in the saliva samples using standard microbiological techniques.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Male or Female 18y - 80y age

  1. In general good health 18 - 80 years of age.
  2. Practice good oral hygiene.

Exclusion criteria

  1. Have a history of autoimmune disease or are immunocompromised.
  2. Are on concurrent antibiotic therapy or regular antibiotic use within last 1 week
  3. History of allergy (e.g. dairy).

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 2 patient groups

Streptococcus salivarius M18 lozenges
Active Comparator group
Description:
Streptococcus salivarius M18 lozenges containing dairy based Streptococcus salivarius M18
Treatment:
Dietary Supplement: Streptococcus salivarius M18 lozenges
Streptococcus salivarius M18 dairy free lozenges
Active Comparator group
Description:
Streptococcus salivarius M18 lozenges containing dairy free Streptococcus salivarius M18
Treatment:
Dietary Supplement: Streptococcus salivarius M18 dairy free lozenges

Trial contacts and locations

1

Loading...

Central trial contact

Rohit Jain, PhD; John D Hale, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems